Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.39 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SNCA | P37840 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CASP3 | P42574 | 1/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.34 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amiloxate SCHEMBL19970643 | 0.88 | LMNA (0.59) | TDP1LMNATAS1R3TAS1R1SMN1; SMN2 | |
| SCHEMBL288562 | 0.87 | TDP1 (0.50) | TDP1LMNAALDH1A1MAPK1MEN1 | |
| SCHEMBL156437 | 0.87 | TDP1 (0.50) | TDP1LMNAALDH1A1MAPK1MEN1 | |
| Octinoxate SCHEMBL20787052 | 0.83 | TDP1 (0.85) | TDP1LMNATAS1R3TAS1R1SMN1; SMN2 | |
| Amiloxate SCHEMBL26646558 | 0.79 | ALDH1A1 (0.64) | TDP1LMNATAS1R3TAS1R1SMN1; SMN2 | |
| Amiloxate SCHEMBL26646557 | 0.79 | ALDH1A1 (0.64) | TDP1LMNATAS1R3TAS1R1SMN1; SMN2 | |
| Octinoxate SCHEMBL15803545 | 0.77 | TDP1 (1.00) | TDP1LMNATAS1R3TAS1R1SMN1; SMN2 | |
| Octinoxate SCHEMBL15609 | 0.77 | TDP1 (1.00) | TDP1LMNATAS1R3TAS1R1SMN1; SMN2 | |
| Octinoxate SCHEMBL39360 | 0.77 | TDP1 (1.00) | TDP1LMNATAS1R3TAS1R1SMN1; SMN2 | |
| Octinoxate SCHEMBL30252195 | 0.77 | TDP1 (1.00) | TDP1LMNATAS1R3TAS1R1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1702674-A1 | Visible beads | Cognis IP Management GmbH (DE) | 2006-09-20 | — | — | EP | disclosed |
| US-20030064106-A1 | Microcapsules-vi | COGNIS IBERIA, S.L. (ES) | 2003-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030064106-A1 | Microcapsules-vi | CHMP4B, LIPA, PHOSPHO1 | TDP1 4186/4885LMNA 909/4885TAS1R3 3597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.